Please assess the completion status of the following clinical trial:

Trial Title: Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* proteinuria \> 1 g/day with ramipril 5 + valsartan 80 mg/day for 2 months~* proteinuria changes \< 50% on 3 separate dosages over 2 months.~Exclusion criteria:~* age \< 18 or \> 80 years systolic BP \< 110 or ≥ 140 mmHg, serum creatinine \> 250 mmole/L~* serum creatinine increase on ramipril + valsartan \> 20%~* intolerance to ACEI or ARB

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).